A reformulated version of an anti-HIV gel developed for vaginal use was found safe and acceptable by HIV-negative men and women who used it rectally, according to a Phase I clinical trial published in PLOS ONE .
http://www.medicalnewstoday.com/releases/258620.php
http://www.medicalnewstoday.com/releases/258620.php
No comments:
Post a Comment